Genome‐Wide In Vivo RNAi Screening Identifies HOXD4 as a Tumor Metastasis Suppressor in Colorectal Cancer
Advanced Science · 2026-09 · 13 (51)
DOI: 10.1002/advs.202520829 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 26.06.2026. Verfasst von Zhi-Hua Ye und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guan…. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Homeodomain Proteins, Neoplasm Metastasis, Forkhead Transcription Factors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Guangzhou Science and Technology Program Key Projects.
Abstract (Originalsprache)
Metastasis remains a major therapeutic challenge in colorectal cancer, highlighting an urgent need to elucidate its underlying molecular mechanisms. In this study, an in vivo screening system integrating genome‐wide short hairpin RNA library and next‐generation sequencing identifies six candidate metastasis suppressors, among which Homeobox D4 (HOXD4) shows the most pronounced effects. Clinicopathological analyses reveal significant HOXD4 downregulation in tumor tissues relative to adjacent normal tissues, with reduced expression strongly correlating with aggressive tumor features. Functional assays demonstrate that HOXD4 depletion enhances migration, invasion, and tumorsphere formation in HCT116 cells, while ectopic HOXD4 overexpression reverses these malignant phenotypes in SW620 cells. Mechanistically, HOXD4 suppresses epithelial‐mesenchymal transition (EMT) by directly binding to the promoter of Forkhead box Q1 (FOXQ1), a key driver of EMT and stemness, and thereby transcriptionally repressing its expression. Immunohistochemistry confirms an inverse correlation between HOXD4 and FOXQ1 expression in clinical specimens. Rescue experiments substantiate that HOXD4 exerts its metastasis‐suppressing functions via FOXQ1 regulation. Collectively, these findings not only establish an efficient platform for screening tumor metastasis suppressors, but also identify HOXD4 as a master transcriptional regulator of the FOXQ1‐EMT axis, providing a promising target for metastasis interception.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China.
- Department of Medical Oncology Center, Zhongshan City People's Hospital, Zhongshan, Guangdong, China.
- Department of Oncology, Qingdao Municipal Hospital, Qingdao, Shandong, China.
- Guiyang Healthcare Vocational University Clinical and Rehabilitation College, Guiyang, Guizhou, China.
- Guangdong Provincial Key Laboratory of Tumor Targeted Drugs & Guangzhou Enterprise Key Laboratory of Gene Medicine, Guangzhou Doublle Bioproducts Co. Ltd., Guangzhou, Guangdong, China.
ORCID-Profile: Wen-Jing Luo, Ran-Yi Liu
Förderung
- National Natural Science Foundation of China
- Guangzhou Science and Technology Program Key Projects
Zitieren
APA
Ye, Z. H., Luo, W. J., Li, L., Shuai, W. D., Zhou, L., Duan, Y. F., Chen, X., Zhang, J. K., Huang, W., & Liu, R. Y. (2026). Genome‐Wide In Vivo RNAi Screening Identifies HOXD4 as a Tumor Metastasis Suppressor in Colorectal Cancer. Advanced Science, 13(51). https://doi.org/10.1002/advs.202520829
Vancouver
Ye ZH, Luo WJ, Li L, Shuai WD, Zhou L, Duan YF, et al. Genome‐Wide In Vivo RNAi Screening Identifies HOXD4 as a Tumor Metastasis Suppressor in Colorectal Cancer. Advanced Science. 2026;13(51). doi:10.1002/advs.202520829
BibTeX
@article{Ye2026,
author = {Ye, Zhi-Hua and Luo, Wen-Jing and Li, Lu and Shuai, Wen-di and Zhou, Ling and Duan, You-Fa and Chen, Xue and Zhang, Jun-Kai and Huang, Wenlin and Liu, Ran-Yi},
title = {Genome‐Wide In Vivo RNAi Screening Identifies HOXD4 as a Tumor Metastasis Suppressor in Colorectal Cancer},
journal = {Advanced Science},
year = {2026},
volume = {13},
number = {51},
doi = {10.1002/advs.202520829}
}
EUVIMED